----
Current ValuationThe current P/E ratio is 79.18, within the reasonable range, cheaper than 45.09% of the time in the past 5 years, and the industry ranks 80/255, the industry Median -0.27.
79.18xP/E
$80.80Stock price
$1.02Earnings per share
79.18xP/E
Stock price$80.80Earnings per share$1.02
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 75.46x
- Typical range
- 22.59x–266.92x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
04080120160
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
SNPSUSSynopsys | 76.54x | 49.10% | $82.40B |
AGYSUSAgilysys | 79.36x | 21.75% | $3.40B |
RDVTUSRed Violet | 79.18x | 18.41% | $1.30B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
